GCP
SNY icon

Gill Capital Partners’s Sanofi SNY Stock Holding History

Gill Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597 Hold
14
– – ﹤0.01% 633
2026
Q1 		$675 Buy
+14
New +$653 ﹤0.01% 617

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Gill Capital Partners's SNY Position: Q2 2026 in Review

Gill Capital Partners held its Sanofi (SNY) position steady in Q2 2026 at 14 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Gill Capital Partners first reported a position in SNY in Q1 2026 and has held it in 2 quarters since. The position peaked at $675 in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Gill Capital Partners held 14 shares of Sanofi worth $597 as of Q2 2026.
  • Gill Capital Partners left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #633 holding.
  • Gill Capital Partners first reported a position in Sanofi in Q1 2026 and has held it in 2 quarters since.
  • Gill Capital Partners's Sanofi position peaked at $675 in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.